Abiraterone
The serum concentration of Pantoprazole can be increased when it is combined with Abiraterone.
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Pantoprazole.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Pantoprazole.
Advertisement
Alendronate
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Pantoprazole.
Alendronic acid
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Pantoprazole.
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Pantoprazole.
Advertisement
Ambrisentan
The metabolism of Ambrisentan can be decreased when combined with Pantoprazole.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Pantoprazole.
Amiodarone
The metabolism of Pantoprazole can be decreased when combined with Amiodarone.
Advertisement
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Pantoprazole.
Amoxicillin
The metabolism of Amoxicillin can be decreased when combined with Pantoprazole.
Amoxicillin Anhydrous
The metabolism of Amoxicillin can be decreased when combined with Pantoprazole.
Amphetamine
Pantoprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Anhydrous Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Pantoprazole.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Pantoprazole.
Apalutamide
The serum concentration of Pantoprazole can be decreased when it is combined with Apalutamide.
Apixaban
The metabolism of Apixaban can be decreased when combined with Pantoprazole.
Aprepitant
The serum concentration of Pantoprazole can be increased when it is combined with Aprepitant.
Arformoterol
The metabolism of Arformoterol can be decreased when combined with Pantoprazole.
Aripiprazole
The serum concentration of Aripiprazole can be decreased when it is combined with Pantoprazole.
Armodafinil
The metabolism of Pantoprazole can be decreased when combined with Armodafinil.
Artemether
The metabolism of Artemether can be decreased when combined with Pantoprazole.
Atazanavir
Pantoprazole can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Atomoxetine
The metabolism of Pantoprazole can be decreased when combined with Atomoxetine.
Axitinib
The metabolism of Axitinib can be decreased when combined with Pantoprazole.
Azelastine
The metabolism of Azelastine can be decreased when combined with Pantoprazole.
Azithromycin
The metabolism of Pantoprazole can be decreased when combined with Azithromycin.
Benztropine
The metabolism of Benzatropine can be decreased when combined with Pantoprazole.
Boceprevir
The metabolism of Pantoprazole can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Pantoprazole can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Pantoprazole can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be decreased when it is combined with Pantoprazole.
Bosutinib monohydrate
The serum concentration of Bosutinib can be decreased when it is combined with Pantoprazole.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Pantoprazole.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Pantoprazole.
Bromazepam
The metabolism of Bromazepam can be decreased when combined with Pantoprazole.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Pantoprazole.
Bupivacaine
The metabolism of Bupivacaine can be decreased when combined with Pantoprazole.
Caffeine
The metabolism of Pantoprazole can be decreased when combined with Caffeine.
Cannabidiol
The metabolism of Cannabidiol can be decreased when combined with Pantoprazole.
Carbamazepine
The metabolism of Pantoprazole can be increased when combined with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Pantoprazole.
Carisoprodol
The metabolism of Carisoprodol can be decreased when combined with Pantoprazole.
Cefditoren
The serum concentration of Cefditoren can be decreased when it is combined with Pantoprazole.
Ceritinib
The serum concentration of Pantoprazole can be increased when it is combined with Ceritinib.
Chloramphenicol
The metabolism of Pantoprazole can be decreased when combined with Chloramphenicol.
Chlormethiazole
The metabolism of clomethiazole can be decreased when combined with Pantoprazole.
Chlorpropamide
The metabolism of Chlorpropamide can be decreased when combined with Pantoprazole.
Cholecalciferol
The metabolism of Pantoprazole can be decreased when combined with Cholecalciferol.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Pantoprazole.
Cimetidine
The metabolism of Pantoprazole can be decreased when combined with Cimetidine.
Cisapride
The metabolism of Cisapride can be decreased when combined with Pantoprazole.
Citalopram
The serum concentration of Citalopram can be increased when it is combined with Pantoprazole.
Clarithromycin
The metabolism of Pantoprazole can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Pantoprazole can be decreased when combined with Clemastine.
Clobazam
The metabolism of Clobazam can be decreased when combined with Pantoprazole.
Clodronic Acid
The therapeutic efficacy of Clodronic Acid can be decreased when used in combination with Pantoprazole.
Clofezone
The metabolism of Rabeprazole can be decreased when combined with Pantoprazole.
Clomipramine
The metabolism of Clomipramine can be decreased when combined with Pantoprazole.
Clopidogrel
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Pantoprazole resulting in a loss in efficacy.
Clotiazepam
The metabolism of Clotiazepam can be decreased when combined with Pantoprazole.
Clotrimazole
The metabolism of Pantoprazole can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Clozapine can be decreased when combined with Pantoprazole.
Cobicistat
The metabolism of Pantoprazole can be decreased when combined with Cobicistat.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Pantoprazole.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Pantoprazole.
Crizotinib
The metabolism of Pantoprazole can be decreased when combined with Crizotinib.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Pantoprazole.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Pantoprazole.
Cyclosporine
The metabolism of Pantoprazole can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Pantoprazole can be decreased when it is combined with Cyproterone acetate.
Cysteamine
The therapeutic efficacy of Cysteamine can be decreased when used in combination with Pantoprazole.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Pantoprazole.
Dabrafenib
The serum concentration of Dabrafenib can be decreased when it is combined with Pantoprazole.
Dapsone
The metabolism of Dapsone can be decreased when combined with Pantoprazole.
Darunavir
The metabolism of Pantoprazole can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Dasatinib can be decreased when it is combined with Pantoprazole.
Dasatinib Anhydrous
The serum concentration of Dasatinib can be decreased when it is combined with Pantoprazole.
Deferasirox
The serum concentration of Pantoprazole can be decreased when it is combined with Deferasirox.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Pantoprazole.
Desipramine
The metabolism of Desipramine can be decreased when combined with Pantoprazole.
Dexlansoprazole
The metabolism of Dexlansoprazole can be decreased when combined with Pantoprazole.
Dexmethylphenidate
Pantoprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextroamphetamine
Pantoprazole can cause an increase in the absorption of Dextroamphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Pantoprazole.
Diazepam
The metabolism of Diazepam can be decreased when combined with Pantoprazole.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Pantoprazole.
Dihydroergotamine
The metabolism of Pantoprazole can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Pantoprazole can be decreased when combined with Diltiazem.
Diphenhydramine
The metabolism of Diphenhydramine can be decreased when combined with Pantoprazole.
Dopamine
The metabolism of Dopamine can be decreased when combined with Pantoprazole.
Dothiepin
The metabolism of Pantoprazole can be decreased when combined with Dosulepin.
Doxazosin
The metabolism of Doxazosin can be decreased when combined with Pantoprazole.
Doxepin
The metabolism of Doxepin can be decreased when combined with Pantoprazole.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Pantoprazole.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Pantoprazole.
Doxycycline
The metabolism of Pantoprazole can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Pantoprazole can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Pantoprazole can be decreased when combined with Dronedarone.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Pantoprazole.
Efavirenz
The metabolism of Pantoprazole can be decreased when combined with Efavirenz.
Eletriptan
The metabolism of Eletriptan can be decreased when combined with Pantoprazole.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Pantoprazole.
Enfuvirtide
The metabolism of Enfuvirtide can be decreased when combined with Pantoprazole.
Enzalutamide
The serum concentration of Pantoprazole can be decreased when it is combined with Enzalutamide.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Pantoprazole.
Erythromycin
The metabolism of Pantoprazole can be decreased when combined with Erythromycin.
Escitalopram
The metabolism of Escitalopram can be decreased when combined with Pantoprazole.
Eslicarbazepine Acetate
The metabolism of Pantoprazole can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Esomeprazole can be decreased when combined with Pantoprazole.
Estradiol
The metabolism of Estradiol can be decreased when combined with Pantoprazole.
Estradiol 3-Benzoate
The metabolism of Estradiol benzoate can be decreased when combined with Pantoprazole.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Pantoprazole.
Estradiol Cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Pantoprazole.
Estradiol Valerate
The metabolism of Estradiol valerate can be decreased when combined with Pantoprazole.
Etidronate
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Pantoprazole.
Etidronic Acid
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Pantoprazole.
Etravirine
The metabolism of Etravirine can be decreased when combined with Pantoprazole.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Pantoprazole.
Famotidine
The metabolism of Famotidine can be decreased when combined with Pantoprazole.
Ferric Carboxymaltose
Pantoprazole can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Pantoprazole can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluconazole
The serum concentration of Pantoprazole can be increased when it is combined with Fluconazole.
Flunitrazepam
The metabolism of Flunitrazepam can be decreased when combined with Pantoprazole.
Fluoxetine
The metabolism of Fluoxetine can be decreased when combined with Pantoprazole.
Flutamide
The metabolism of Flutamide can be decreased when combined with Pantoprazole.
Fluvoxamine
The metabolism of Pantoprazole can be decreased when combined with Fluvoxamine.
Formoterol
The metabolism of Formoterol can be decreased when combined with Pantoprazole.
Fosamprenavir
The metabolism of Pantoprazole can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Pantoprazole can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Pantoprazole can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Pantoprazole can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Pantoprazole can be increased when it is combined with Fusidic Acid.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Pantoprazole.
Gemfibrozil
The metabolism of Pantoprazole can be decreased when combined with Gemfibrozil.
Gliclazide
The metabolism of Gliclazide can be decreased when combined with Pantoprazole.
Glucosamine
The metabolism of Glucosamine can be decreased when combined with Pantoprazole.
Glyburide
The metabolism of Glyburide can be decreased when combined with Pantoprazole.
Guanfacine
The metabolism of Guanfacine can be decreased when combined with Pantoprazole.
Haloperidol
The metabolism of Haloperidol can be decreased when combined with Pantoprazole.
Hexobarbital
The metabolism of Hexobarbital can be decreased when combined with Pantoprazole.
Hypoxis hemerocallidea root extract
The serum concentration of Pantoprazole can be decreased when it is combined with St. John's Wort.
Ibandronate
The therapeutic efficacy of Ibandronate can be decreased when used in combination with Pantoprazole.
Ibandronic Acid
The therapeutic efficacy of Ibandronate can be decreased when used in combination with Pantoprazole.
Ibuprofen
The metabolism of Ibuprofen can be decreased when combined with Pantoprazole.
Idelalisib
The metabolism of Pantoprazole can be decreased when combined with Idelalisib.
Ifosfamide
The metabolism of Ifosfamide can be decreased when combined with Pantoprazole.
Imatinib
The metabolism of Pantoprazole can be decreased when combined with Imatinib.
Imipramine
The metabolism of Imipramine can be decreased when combined with Pantoprazole.
Indinavir
The serum concentration of Indinavir can be decreased when it is combined with Pantoprazole.
INDINAVIR ANHYDROUS
The serum concentration of Indinavir can be decreased when it is combined with Pantoprazole.
Indomethacin
The metabolism of Indomethacin can be decreased when combined with Pantoprazole.
Iron
Pantoprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Pantoprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
Pantoprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
Pantoprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isavuconazole
The serum concentration of Pantoprazole can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Pantoprazole can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Pantoprazole can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Pantoprazole can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.
Ivacaftor
The serum concentration of Pantoprazole can be increased when it is combined with Ivacaftor.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Pantoprazole.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Pantoprazole.
Lapatinib
The metabolism of Lapatinib can be decreased when combined with Pantoprazole.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Pantoprazole.
Levomilnacipran
The metabolism of Levomilnacipran can be decreased when combined with Pantoprazole.
Lidocaine
The metabolism of Pantoprazole can be decreased when combined with Lidocaine.
Lopinavir
The metabolism of Pantoprazole can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Lorcaserin can be decreased when combined with Pantoprazole.
Lovastatin
The metabolism of Pantoprazole can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Pantoprazole can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Pantoprazole can be decreased when it is combined with Lumacaftor.
Macitentan
The metabolism of Macitentan can be decreased when combined with Pantoprazole.
Medronate
The therapeutic efficacy of Technetium Tc-99m medronate can be decreased when used in combination with Pantoprazole.
Melatonin
The metabolism of Melatonin can be decreased when combined with Pantoprazole.
Meperidine
The metabolism of Pethidine can be decreased when combined with Pantoprazole.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Pantoprazole.
Mephobarbital
The metabolism of Methylphenobarbital can be decreased when combined with Pantoprazole.
Meprobamate
The metabolism of Meprobamate can be decreased when combined with Pantoprazole.
Mesalamine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Pantoprazole.
Methadone
The metabolism of Methadone can be decreased when combined with Pantoprazole.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Pantoprazole.
Methsuximide
The metabolism of Methsuximide can be decreased when combined with Pantoprazole.
Methylphenidate
Pantoprazole can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Metoprolol
The metabolism of Metoprolol can be decreased when combined with Pantoprazole.
Mexiletine
The metabolism of Pantoprazole can be decreased when combined with Mexiletine.
Midostaurin
The metabolism of Pantoprazole can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Pantoprazole can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Pantoprazole can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Moclobemide can be decreased when combined with Pantoprazole.
Modafinil
The metabolism of Pantoprazole can be decreased when combined with Modafinil.
MYCOPHENOLATE
The serum concentration of Mycophenolic acid can be decreased when it is combined with Pantoprazole.
Mycophenolic Acid
The serum concentration of Mycophenolic acid can be decreased when it is combined with Pantoprazole.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Pantoprazole.
Nefazodone
The metabolism of Pantoprazole can be decreased when combined with Nefazodone.
Nelfinavir
The serum concentration of the active metabolites of Nelfinavir can be reduced when Nelfinavir is used in combination with Pantoprazole resulting in a loss in efficacy.
Netupitant
The serum concentration of Pantoprazole can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Pantoprazole can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Pantoprazole can be decreased when combined with Nicardipine.
Nicotine
The metabolism of Nicotine can be decreased when combined with Pantoprazole.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Pantoprazole.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Pantoprazole.
Nilutamide
The metabolism of Nilutamide can be decreased when combined with Pantoprazole.
Nortriptyline
The metabolism of Nortriptyline can be decreased when combined with Pantoprazole.
Olaparib
The metabolism of Pantoprazole can be decreased when combined with Olaparib.
Omeprazole
The metabolism of Omeprazole can be decreased when combined with Pantoprazole.
Osimertinib
The serum concentration of Pantoprazole can be increased when it is combined with Osimertinib.
Ospemifene
The metabolism of Ospemifene can be decreased when combined with Pantoprazole.
Oxiconazole
The metabolism of Oxiconazole can be decreased when combined with Pantoprazole.
Palbociclib
The serum concentration of Pantoprazole can be increased when it is combined with Palbociclib.
Pamidronate
The therapeutic efficacy of Pamidronate can be decreased when used in combination with Pantoprazole.
Pamidronic Acid
The therapeutic efficacy of Pamidronate can be decreased when used in combination with Pantoprazole.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Pantoprazole.
Peginterferon Alfa-2b
The serum concentration of Pantoprazole can be increased when it is combined with Peginterferon alfa-2b.
Pentamidine
The metabolism of Pentamidine can be decreased when combined with Pantoprazole.
Pentobarbital
The metabolism of Pantoprazole can be increased when combined with Pentobarbital.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Pantoprazole.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Pantoprazole.
Phenobarbital
The metabolism of Pantoprazole can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Pantoprazole can be increased when combined with Phenytoin.
Pipothiazine
The metabolism of Pipotiazine can be decreased when combined with Pantoprazole.
Podofilox
The metabolism of Podofilox can be decreased when combined with Pantoprazole.
Posaconazole
The serum concentration of Posaconazole can be decreased when it is combined with Pantoprazole.
Prasugrel
The metabolism of Prasugrel can be decreased when combined with Pantoprazole.
Praziquantel
The metabolism of Praziquantel can be decreased when combined with Pantoprazole.
Primidone
The metabolism of Pantoprazole can be increased when combined with Primidone.
Progesterone
The metabolism of Progesterone can be decreased when combined with Pantoprazole.
Proguanil
The metabolism of Proguanil can be decreased when combined with Pantoprazole.
Promazine
The metabolism of Promazine can be decreased when combined with Pantoprazole.
Propofol
The metabolism of Propofol can be decreased when combined with Pantoprazole.
Propranolol
The metabolism of Propranolol can be decreased when combined with Pantoprazole.
Quazepam
The metabolism of Quazepam can be decreased when combined with Pantoprazole.
Quetiapine
The metabolism of Quetiapine can be decreased when combined with Pantoprazole.
Quetiapine fumarate
The metabolism of Quetiapine can be decreased when combined with Pantoprazole.
Quinine
The metabolism of Quinine can be decreased when combined with Pantoprazole.
Rabeprazole
The metabolism of Rabeprazole can be decreased when combined with Pantoprazole.
Raltegravir
The serum concentration of Raltegravir can be increased when it is combined with Pantoprazole.
Ramelteon
The metabolism of Ramelteon can be decreased when combined with Pantoprazole.
Ranitidine
The metabolism of Ranitidine can be decreased when combined with Pantoprazole.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Pantoprazole.
Rifabutin
The metabolism of Pantoprazole can be increased when combined with Rifabutin.
Rifampin
The metabolism of Pantoprazole can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Pantoprazole can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Pantoprazole.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Pantoprazole.
Riociguat
The serum concentration of Riociguat can be decreased when it is combined with Pantoprazole.
Risedronate
The therapeutic efficacy of Risedronate can be decreased when used in combination with Pantoprazole.
Risedronic Acid
The therapeutic efficacy of Risedronate can be decreased when used in combination with Pantoprazole.
Romidepsin
The metabolism of Romidepsin can be decreased when combined with Pantoprazole.
Ropinirole
The metabolism of Pantoprazole can be decreased when combined with Ropinirole.
Rosuvastatin
The metabolism of Rosuvastatin can be decreased when combined with Pantoprazole.
Rucaparib
The metabolism of Pantoprazole can be decreased when combined with Rucaparib.
Saquinavir
The serum concentration of Saquinavir can be increased when it is combined with Pantoprazole.
Saquinavir Mesylate
The serum concentration of Saquinavir can be increased when it is combined with Pantoprazole.
Sarilumab
The therapeutic efficacy of Pantoprazole can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Saxagliptin can be decreased when it is combined with Pantoprazole.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be decreased when it is combined with Pantoprazole.
Selegiline
The metabolism of Selegiline can be decreased when combined with Pantoprazole.
Sertraline
The metabolism of Sertraline can be decreased when combined with Pantoprazole.
Sildenafil
The metabolism of Pantoprazole can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Pantoprazole.
Siltuximab
The serum concentration of Pantoprazole can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Pantoprazole can be increased when it is combined with Simeprevir.
ST. JOHN'S WORT EXTRACT
The serum concentration of Pantoprazole can be decreased when it is combined with St. John's Wort.
Sucroferric Oxyhydroxide
Pantoprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sulfisoxazole
The metabolism of Pantoprazole can be decreased when combined with Sulfisoxazole.
Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Pantoprazole.
Tamoxifen
The metabolism of Tamoxifen can be decreased when combined with Pantoprazole.
Tapentadol
The metabolism of Tapentadol can be decreased when combined with Pantoprazole.
Technetium Tc 99m Medronate
The therapeutic efficacy of Technetium Tc-99m medronate can be decreased when used in combination with Pantoprazole.
Telaprevir
The metabolism of Pantoprazole can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Pantoprazole can be decreased when combined with Telithromycin.
Temazepam
The metabolism of Temazepam can be decreased when combined with Pantoprazole.
Teniposide
The metabolism of Teniposide can be decreased when combined with Pantoprazole.
Tenofovir Disoproxil
The metabolism of Pantoprazole can be decreased when combined with Tenofovir disoproxil.
Terbinafine
The metabolism of Terbinafine can be decreased when combined with Pantoprazole.
Teriflunomide
The serum concentration of Pantoprazole can be decreased when it is combined with Teriflunomide.
Testosterone
The metabolism of Testosterone can be decreased when combined with Pantoprazole.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Pantoprazole.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Pantoprazole.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Pantoprazole.
Tetrahydrocannabinol
The metabolism of Dronabinol can be decreased when combined with Pantoprazole.
Thalidomide
The metabolism of Thalidomide can be decreased when combined with Pantoprazole.
Theophylline
The metabolism of Pantoprazole can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Pantoprazole can be decreased when combined with Theophylline.
Thioridazine
The metabolism of Thioridazine can be decreased when combined with Pantoprazole.
Ticlopidine
The metabolism of Pantoprazole can be decreased when combined with Ticlopidine.
Tiludronate
The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Pantoprazole.
Tiludronic Acid
The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Pantoprazole.
Timolol
The metabolism of Timolol can be decreased when combined with Pantoprazole.
Timolol Anhydrous
The metabolism of Timolol can be decreased when combined with Pantoprazole.
Tipranavir
The serum concentration of Pantoprazole can be decreased when it is combined with Tipranavir.
Tocilizumab
The serum concentration of Pantoprazole can be decreased when it is combined with Tocilizumab.
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Pantoprazole.
Tolbutamide
The metabolism of Tolbutamide can be decreased when combined with Pantoprazole.
Tolterodine
The metabolism of Tolterodine can be decreased when combined with Pantoprazole.
Topiramate
The metabolism of Pantoprazole can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Pantoprazole.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Pantoprazole.
Tranylcypromine
The metabolism of Pantoprazole can be decreased when combined with Tranylcypromine.
Trimethadione
The metabolism of Trimethadione can be decreased when combined with Pantoprazole.
Trimipramine
The metabolism of Trimipramine can be decreased when combined with Pantoprazole.
Troglitazone
The metabolism of Troglitazone can be decreased when combined with Pantoprazole.
Valproate
The metabolism of Valproic Acid can be decreased when combined with Pantoprazole.
Valproic Acid
The metabolism of Valproic Acid can be decreased when combined with Pantoprazole.
Vemurafenib
The serum concentration of Pantoprazole can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Pantoprazole can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Pantoprazole can be decreased when combined with Verapamil.
Vincristine
The excretion of Vincristine can be decreased when combined with Pantoprazole.
Voriconazole
The serum concentration of Pantoprazole can be increased when it is combined with Voriconazole.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Pantoprazole.
Warfarin
The metabolism of Warfarin can be decreased when combined with Pantoprazole.
Zidovudine
The metabolism of Zidovudine can be decreased when combined with Pantoprazole.
Ziprasidone
The metabolism of Pantoprazole can be decreased when combined with Ziprasidone.
Zoledronic Acid
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Pantoprazole.
Zoledronic Acid Anhydrous
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Pantoprazole.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Pantoprazole.
